These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18297528)

  • 1. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
    Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
    Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features.
    Fagioli F; Cuneo A; Carli MG; Bardi A; Piva N; Previati R; Rigolin GM; Ferrari L; Spanedda R; Castoldi G
    Cancer Genet Cytogenet; 1993 Dec; 71(2):119-24. PubMed ID: 7506635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
    Grimwade D; Hills RK; Moorman AV; Walker H; Chatters S; Goldstone AH; Wheatley K; Harrison CJ; Burnett AK;
    Blood; 2010 Jul; 116(3):354-65. PubMed ID: 20385793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
    Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
    Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
    Merlat A; Lai JL; Sterkers Y; Demory JL; Bauters F; Preudhomme C; Fenaux P
    Leukemia; 1999 Feb; 13(2):250-7. PubMed ID: 10025899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOES THE PATTERN OF CLONAL EVOLUTION IN THE KARYOTYPE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES DEPEND ON THE TYPE OF THE PRIMARY CHROMOSOMAL ABERRATIONS?
    Angelova S; Spassov B; Nikolova V; Christov I; Tzvetkov N; Simeonova M
    Tsitol Genet; 2015; 49(4):17-24. PubMed ID: 26419065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.
    Poiré X; Labopin M; Polge E; Volin L; Finke J; Ganser A; Blaise D; Yakoub-Agha I; Beelen D; Forcade E; Lioure B; Socié G; Niederwieser D; Labussière-Wallet H; Maertens J; Cornelissen J; Craddock C; Mohty M; Esteve J; Nagler A
    Am J Hematol; 2020 Mar; 95(3):282-294. PubMed ID: 31876307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
    Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
    Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.
    Hasle H; Alonzo TA; Auvrignon A; Behar C; Chang M; Creutzig U; Fischer A; Forestier E; Fynn A; Haas OA; Harbott J; Harrison CJ; Heerema NA; van den Heuvel-Eibrink MM; Kaspers GJ; Locatelli F; Noellke P; Polychronopoulou S; Ravindranath Y; Razzouk B; Reinhardt D; Savva NN; Stark B; Suciu S; Tsukimoto I; Webb DK; Wojcik D; Woods WG; Zimmermann M; Niemeyer CM; Raimondi SC
    Blood; 2007 Jun; 109(11):4641-7. PubMed ID: 17299091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.
    Leung GMK; Zhang C; Ng NKL; Yang N; Lam SSY; Au CH; Chan TL; Ma ESK; Tsui SP; Ip HW; So JCC; Ng MHL; Cheng KCK; Wong KF; Siu LLP; Yip SF; Lin SY; Lau JSM; Luk TH; Lee HKK; Lau CK; Kho B; Kwong YL; Leung AYH
    Am J Hematol; 2019 Jun; 94(6):650-657. PubMed ID: 30900772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
    El-Menoufy MAM; Mourad ZI; Farahat NM
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiprobe fluorescence in situ hybridization panel in detection of the common cytogenetic abnormalities of acute myeloid leukemia].
    Xu LL; Liu XL; Du QF; Song LL; Cao R; Wei YQ; Xu N; Zhang JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):324-6. PubMed ID: 21638933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.
    Middeke JM; Beelen D; Stadler M; Göhring G; Schlegelberger B; Baurmann H; Bug G; Bellos F; Mohr B; Buchholz S; Schwerdtfeger R; Martin H; Hegenbart U; Ehninger G; Bornhäuser M; Schetelig J;
    Blood; 2012 Sep; 120(12):2521-8. PubMed ID: 22855604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.